Andrea Kießling

2.0k total citations
39 papers, 1.4k citations indexed

About

Andrea Kießling is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Andrea Kießling has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 15 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Andrea Kießling's work include Immunotherapy and Immune Responses (12 papers), Biosimilars and Bioanalytical Methods (10 papers) and CAR-T cell therapy research (9 papers). Andrea Kießling is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), Biosimilars and Bioanalytical Methods (10 papers) and CAR-T cell therapy research (9 papers). Andrea Kießling collaborates with scholars based in Germany, Switzerland and United States. Andrea Kießling's co-authors include Bernd Weigle, Marc Schmitz, E. Peter Rieber, Michael Bachmann, Achim Temme, Michael A. Rieger, Manfred P. Wirth, S. Füssel, Frank R. Brennan and Rebekka Wehner and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Andrea Kießling

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Kießling Germany 20 657 591 434 284 160 39 1.4k
Shengzhang Lin China 15 354 0.5× 489 0.8× 499 1.1× 51 0.2× 138 0.9× 35 1.4k
Juliette Humeau France 13 724 1.1× 635 1.1× 802 1.8× 38 0.1× 281 1.8× 29 1.9k
Jiandong Zhao China 15 93 0.1× 379 0.6× 227 0.5× 167 0.6× 208 1.3× 44 1.1k
Zhaojin Yu China 23 286 0.4× 1.1k 1.9× 532 1.2× 124 0.4× 128 0.8× 63 1.7k
Eric S. Day United States 16 395 0.6× 766 1.3× 202 0.5× 211 0.7× 17 0.1× 25 1.4k
Rémy Castellano France 24 1.0k 1.6× 968 1.6× 803 1.9× 58 0.2× 81 0.5× 49 2.3k
Steven Grant United States 24 385 0.6× 1.2k 2.1× 794 1.8× 130 0.5× 126 0.8× 35 2.1k
Wenting Liu China 18 264 0.4× 512 0.9× 212 0.5× 80 0.3× 113 0.7× 58 1.3k
Sinisa Dovat United States 28 366 0.6× 1.0k 1.7× 280 0.6× 23 0.1× 57 0.4× 105 2.1k
Girieca Lorusso Switzerland 19 304 0.5× 603 1.0× 553 1.3× 59 0.2× 126 0.8× 25 1.3k

Countries citing papers authored by Andrea Kießling

Since Specialization
Citations

This map shows the geographic impact of Andrea Kießling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Kießling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Kießling more than expected).

Fields of papers citing papers by Andrea Kießling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Kießling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Kießling. The network helps show where Andrea Kießling may publish in the future.

Co-authorship network of co-authors of Andrea Kießling

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Kießling. A scholar is included among the top collaborators of Andrea Kießling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Kießling. Andrea Kießling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hey, Adam, Andreas Baumann, Sven Kronenberg, et al.. (2021). Nonclinical Development of Biologics: Integrating Safety, Pharmacokinetics, and Pharmacodynamics to Create Smarter and More Flexible Nonclinical Safety Programs Optimizing Animal Use. International Journal of Toxicology. 40(3). 270–284. 2 indexed citations
2.
Ulrich, Peter, Andreas Baumann, Adam Hey, et al.. (2018). Biotherapeutics in non-clinical development: Strengthening the interface between safety, pharmacokinetics-pharmacodynamics and manufacturing. Regulatory Toxicology and Pharmacology. 94. 91–100. 6 indexed citations
3.
Atienzar, Franck, Annie Delaunois, Helga H.J. Gerets, et al.. (2016). Investigative safety strategies to improve success in drug development. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 2(1). 2–2. 11 indexed citations
4.
Brennan, Frank R. & Andrea Kießling. (2016). Translational immunotoxicology of immunomodulatory monoclonal antibodies. Drug Discovery Today Technologies. 21-22. 85–93. 2 indexed citations
5.
6.
Brennan, Frank R., Andreas Baumann, Lolke de Haan, et al.. (2015). Nonclinical safety testing of biopharmaceuticals – Addressing current challenges of these novel and emerging therapies. Regulatory Toxicology and Pharmacology. 73(1). 265–275. 13 indexed citations
7.
Finco, Deborah, Christine Grimaldi, Madeline Fort, et al.. (2014). Cytokine release assays: Current practices and future directions. Cytokine. 66(2). 143–155. 64 indexed citations
8.
Brennan, Frank R., Laura Dill Morton, Sebastian Spindeldreher, et al.. (2010). Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies. mAbs. 2(3). 233–255. 163 indexed citations
9.
Kießling, Andrea, et al.. (2009). Expression, regulation and function of the ISGylation system in prostate cancer. Oncogene. 28(28). 2606–2620. 54 indexed citations
10.
Lamounier‐Zepter, Valéria, Stefan R. Bornstein, Jaroslav Kuneš, et al.. (2007). Adrenocortical changes and arterial hypertension in lipoatrophic A-ZIP/F-1 mice. Molecular and Cellular Endocrinology. 280(1-2). 39–46. 14 indexed citations
11.
Kießling, Andrea, S. Füssel, Rebekka Wehner, et al.. (2007). Advances in Specific Immunotherapy for Prostate Cancer. European Urology. 53(4). 694–708. 44 indexed citations
12.
Schmitz, Marc, Senming Zhao, Yvonne Deuse, et al.. (2005). Tumoricidal Potential of Native Blood Dendritic Cells: Direct Tumor Cell Killing and Activation of NK Cell-Mediated Cytotoxicity. The Journal of Immunology. 174(7). 4127–4134. 68 indexed citations
13.
Kießling, Andrea, Bernd Weigle, Susanne Fuessel, et al.. (2005). D‐TMPP: A novel androgen‐regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene family. The Prostate. 64(4). 387–400. 14 indexed citations
14.
Weigle, Bernd, et al.. (2005). Tissue-specificity of prostate specific antigens: Comparative analysis of transcript levels in prostate and non-prostatic tissues. Cancer Letters. 236(2). 229–238. 112 indexed citations
15.
Weigle, Bernd, Susanne Fuessel, Reinhard Ebner, et al.. (2004). D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostate. Biochemical and Biophysical Research Communications. 322(1). 239–249. 21 indexed citations
16.
Weigle, Bernd, Andrea Kießling, Reinhard Ebner, et al.. (2004). D‐PCa‐2: A novel transcript highly overexpressed in human prostate and prostate cancer. International Journal of Cancer. 109(6). 882–892. 5 indexed citations
17.
Kießling, Andrea, Stefan Stevanović, S. Füssel, et al.. (2004). Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein prostein. British Journal of Cancer. 90(5). 1034–1040. 26 indexed citations
18.
Fuessel, Susanne, Andrea Kießling, Marc Schmitz, et al.. (2004). 419: Identification of an HLA-A*0201-Restricted T Cell Epitope Derived from the Prostate Cancer-Associated Protein TRP-P8. The Journal of Urology. 171(4S). 110–111. 4 indexed citations
19.
Kießling, Andrea, S. Füssel, Marc Schmitz, et al.. (2003). Identification of an HLA‐A*0201‐restricted T‐cell epitope derived from the prostate cancer‐associated protein trp‐p8. The Prostate. 56(4). 270–279. 45 indexed citations
20.
Kießling, Andrea, Marc Schmitz, Stefan Stevanović, et al.. (2002). Prostate stem cell antigen: Identification of immunogenic peptides and assessment of reactive CD8+ T cells in prostate cancer patients. International Journal of Cancer. 102(4). 390–397. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shengzhang Lin Breakdown of academic impact, for papers by Juliette Humeau Breakdown of academic impact, for papers by Jiandong Zhao Breakdown of academic impact, for papers by Zhaojin Yu Breakdown of academic impact, for papers by Eric S. Day Breakdown of academic impact, for papers by Rémy Castellano Breakdown of academic impact, for papers by Steven Grant Breakdown of academic impact, for papers by Wenting Liu Breakdown of academic impact, for papers by Sinisa Dovat Breakdown of academic impact, for papers by Girieca Lorusso
Rankless by CCL
2026